José A. Galván

2.8k total citations · 1 hit paper
48 papers, 1.6k citations indexed

About

José A. Galván is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, José A. Galván has authored 48 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 15 papers in Molecular Biology and 10 papers in Epidemiology. Recurrent topics in José A. Galván's work include Cancer Cells and Metastasis (11 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). José A. Galván is often cited by papers focused on Cancer Cells and Metastasis (11 papers), Colorectal Cancer Treatments and Studies (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). José A. Galván collaborates with scholars based in Switzerland, Spain and Germany. José A. Galván's co-authors include Inti Zlobec, Alessandro Lugli, Heather Dawson, Qiqun Zeng, Douglas Hanahan, Hugh P. C. Robinson, Peng Zhang, Sadegh Saghafinia, Wei Jiao and Graham Knott and has published in prestigious journals such as Nature, Science and SHILAP Revista de lepidopterología.

In The Last Decade

José A. Galván

47 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synaptic proximity enables NMDAR signalling to promote brain metastasis

2019 352 citations Qiqun Zeng, José A. Galván et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
José A. Galván Switzerland	22	675	672	275	274	227	48	1.6k
Tadahisa Shono Japan	21	391 0.6×	956 1.4×	551 2.0×	138 0.5×	228 1.0×	64	2.2k
Jiefeng Cui China	29	557 0.8×	1.0k 1.5×	599 2.2×	164 0.6×	170 0.7×	72	2.1k
Helle Broholm Denmark	27	316 0.5×	728 1.1×	428 1.6×	279 1.0×	358 1.6×	91	2.1k
Erik J. Uhlmann United States	30	734 1.1×	1.7k 2.5×	447 1.6×	589 2.1×	209 0.9×	73	3.4k
Gargi D. Basu United States	20	977 1.4×	793 1.2×	344 1.3×	244 0.9×	62 0.3×	53	2.0k
Giuseppe Lamorte Italy	22	804 1.2×	1.5k 2.2×	441 1.6×	144 0.5×	148 0.7×	44	2.5k
Simon J. Furney Ireland	21	647 1.0×	1.0k 1.5×	311 1.1×	146 0.5×	65 0.3×	47	1.8k
Géza Sáfrány Hungary	27	489 0.7×	777 1.2×	291 1.1×	361 1.3×	85 0.4×	75	2.0k
Lauri Miller United States	12	444 0.7×	998 1.5×	387 1.4×	348 1.3×	121 0.5×	16	2.1k
Heidi L. Kenerson United States	23	518 0.8×	801 1.2×	202 0.7×	274 1.0×	191 0.8×	45	1.7k

Countries citing papers authored by José A. Galván

Since Specialization

Citations

This map shows the geographic impact of José A. Galván's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by José A. Galván with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites José A. Galván more than expected).

Fields of papers citing papers by José A. Galván

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by José A. Galván. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by José A. Galván. The network helps show where José A. Galván may publish in the future.

Co-authorship network of co-authors of José A. Galván

This figure shows the co-authorship network connecting the top 25 collaborators of José A. Galván. A scholar is included among the top collaborators of José A. Galván based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with José A. Galván. José A. Galván is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Noti, Luca, José A. Galván, Inti Zlobec, et al.. (2023). Spatial distribution of CD3- and CD8-positive lymphocytes as pretest for POLE wild-type in molecular subgroups of endometrial carcinoma. Frontiers in Medicine. 10. 1110529–1110529.

Grüter, Basil E., Stefan Wanderer, Michael von Gunten, et al.. (2023). Topographic distribution of inflammation factors in a healing aneurysm. Journal of Neuroinflammation. 20(1). 182–182. 1 indexed citations

Genitsch, Vera, Geert van Geest, José A. Galván, et al.. (2023). Targeted removal of macrophage-secreted interleukin-1 receptor antagonist protects against lethal Candida albicans sepsis. Immunity. 56(8). 1743–1760.e9. 18 indexed citations

Widmer, Carmen A., Paul Essers, Zuzanna Nowicka, et al.. (2022). Loss of the Volume-regulated Anion Channel Components LRRC8A and LRRC8D Limits Platinum Drug Efficacy. Cancer Research Communications. 2(10). 1266–1281. 9 indexed citations

Noti, Luca, José A. Galván, Heather Dawson, et al.. (2022). A combined spatial score of granzyme B and CD68 surpasses CD8 as an independent prognostic factor in TNM stage II colorectal cancer. BMC Cancer. 22(1). 987–987. 8 indexed citations

Tschan, Mario P., et al.. (2022). Immunohistochemical Detection of the Chaperone-Mediated Autophagy Markers LAMP2A and HSPA8 in Formalin-Fixed and Paraffin-Embedded Tissues. Methods in molecular biology. 2566. 141–147. 1 indexed citations

Berezowska, Sabina & José A. Galván. (2022). Immunohistochemical Detection of the Autophagy Markers LC3 and p62/SQSTM1 in Formalin-Fixed and Paraffin-Embedded Tissue. Methods in molecular biology. 2566. 133–139. 1 indexed citations

Richard, François, Tilman T. Rau, José A. Galván, et al.. (2020). MAGI1, a New Potential Tumor Suppressor Gene in Estrogen Receptor Positive Breast Cancer. Cancers. 12(1). 223–223. 14 indexed citations

Rau, Tilman T., José A. Galván, Irıs D. Nagtegaal, et al.. (2020). Tumour budding and CD8⁺ T cells: ‘attackers’ and ‘defenders’ in rectal cancer with and without neoadjuvant chemoradiotherapy. Histopathology. 78(7). 1009–1018. 7 indexed citations

10.

Fernández‐García, María Teresa, Fernando Vázquez, Laura Suárez–Fernández, et al.. (2020). A new aggressive xenograft model of human colon cancer using cancer-associated fibroblasts. PeerJ. 8. e9045–e9045. 4 indexed citations

11.

Galván, José A., et al.. (2019). Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma. Human Pathology. 87. 18–27. 30 indexed citations

12.

Dislich, Bastian, Viktor H. Koelzer, José A. Galván, et al.. (2018). Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients. Clinical Colorectal Cancer. 18(1). e20–e38. 61 indexed citations

13.

Li, Leanne, Qiqun Zeng, Arjun Bhutkar, et al.. (2018). GKAP Acts as a Genetic Modulator of NMDAR Signaling to Govern Invasive Tumor Growth. Cancer Cell. 33(4). 736–751.e5. 58 indexed citations

14.

Galván, José A., Micha David Eichmann, Tilman T. Rau, et al.. (2018). CDX2 in colorectal cancer is an independent prognostic factor and regulated by promoter methylation and histone deacetylation in tumors of the serrated pathway. Clinical Epigenetics. 10(1). 120–120. 46 indexed citations

15.

Berezowska, Sabina, José A. Galván, Rupert Langer, et al.. (2017). Glycine decarboxylase and HIF-1α expression are negative prognostic factors in primary resected early-stage non-small cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 470(3). 323–330. 20 indexed citations

16.

Marti, Nesa, Jana Malíková, José A. Galván, et al.. (2017). Androgen production in pediatric adrenocortical tumors may occur via both the classic and/or the alternative backdoor pathway. Molecular and Cellular Endocrinology. 452. 64–73. 8 indexed citations

17.

Wartenberg, Martin, Stefan Haemmig, Erik Vassella, et al.. (2016). PTEN alterations of the stromal cells characterise an aggressive subpopulation of pancreatic cancer with enhanced metastatic potential. European Journal of Cancer. 65. 80–90. 18 indexed citations

18.

Vázquez, Fernando, José A. Galván, Jorge García–Martínez, et al.. (2015). COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression. Tumor Biology. 36(4). 2213–2222. 98 indexed citations

19.

Aguirre, Alina, Inés López-Alonso, Adrián González-López, et al.. (2014). Defective autophagy impairs ATF3 activity and worsens lung injury during endotoxemia. Journal of Molecular Medicine. 92(6). 665–676. 47 indexed citations

20.

Galván, José A., et al.. (2013). Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer. PLoS ONE. 8(10). e78327–e78327. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact